Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart A Westerman

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Nature Genetics|June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation statesTim van Groningen, Jan Koster, Linda J Valentijn, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Nature Cancer|August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cyclingWies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Cancer Cell|May 30, 2025
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C Knol, Mengge Lyu, Franziska Böttger, et al.
Nature|November 22, 2019
Longitudinal molecular trajectories of diffuse glioma in adultsFloris P Barthel, Kevin C Johnson, Frederick S Varn, et al.
Cancer Cell|September 2, 2022
Detection and localization of early- and late-stage cancers using platelet RNASjors G J G In 't Veld, Mohammad Arkani, Edward Post, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Nature Genetics|June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation statesTim van Groningen, Jan Koster, Linda J Valentijn, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Nature Cancer|August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cyclingWies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Cancer Cell|May 30, 2025
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C Knol, Mengge Lyu, Franziska Böttger, et al.
Nature|November 22, 2019
Longitudinal molecular trajectories of diffuse glioma in adultsFloris P Barthel, Kevin C Johnson, Frederick S Varn, et al.
Cancer Cell|September 2, 2022
Detection and localization of early- and late-stage cancers using platelet RNASjors G J G In 't Veld, Mohammad Arkani, Edward Post, et al.
Pageof 5